-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… 870,982 diagnosed lung cancer cases and 766,898 lung cancer-related deaths in … lung cancer (NSCLC) accounts for the majority (80% - 85%) of all lung cancers … of lung cancer, with the combination of tislelizumab 200 mg and docetaxel 150 …
-
Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients
27 Mar 2025 20:15 GMT
Candel Therapeutics, Inc. CADL on Wednesday revealed final survival data from a phase 2a trial of CAN-2409 in patients with stage III/IV NSCLC, inadequately responding to Immune Checkpoint Inhibitor (ICI) treatment.
The median overall survival (mOS) …
-
RYBREVANT® (Amivantamab-Vmjw) Plus LAZCLUZETM (Lazertinib) Outperforms Osimertinib With A Significant And Unprecedented Overall Survival Benefit In Patients With EGFR-Mutated Non-Small Cell Lung Cancer
26 Mar 2025 21:48 GMT
… metastatic non-small cell lung cancer (NSCLC) with epidermal … .D., Vice President, Lung Cancer Disease Area Stronghold Leader, … study assessing RYBREVANT® and docetaxel combination therapy in patients … Non-Small Cell Lung Cancer
Worldwide, lung cancer is one of …
-
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
26 Mar 2025 20:05 GMT
… Leslye Heisler Professor for Lung Cancer Excellence at the University … of care treatment of docetaxel chemotherapy and other therapies … receiving standard of care docetaxel chemotherapy.(1,2)
Systemic … in both non-small cell lung cancer (NSCLC) and pancreatic …
-
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
25 Mar 2025 12:30 GMT
… refractory extensive small cell lung cancer,” said Thomas Zindrick, … in relapsed/refractory lung cancer, we anticipate demonstrating … refractory extensive small cell lung cancer patients. The Phase … compared to docetaxel in non-small-cell lung cancer. The …
-
Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer
18 Mar 2025 17:02 GMT
… patients with non–small cell lung cancer (NSCLC)?
VOKES: The …
[In] patients with metastatic lung cancer who have a targetable driver … they’re comparable to docetaxel.7
What do you do … Study of Lung Cancer global survey on molecular testing in lung cancer. J …
-
Kelun-Biotech first to bag TROP2 approval in lung cancer
13 Mar 2025 12:45 GMT
… conjugate to regulatory approval in lung cancer, getting a green light … non-squamous non-small cell lung cancer (NSCLC) in patients … monotherapy to chemotherapy with docetaxel and achieved a statistically … in this type of lung cancer. The approval is also …
-
Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
26 Feb 2025 18:00 GMT
… diagnosing NSCLC and other lung cancers can be challenging … Teliso-V to docetaxel in patients with … small Cell Lung Cancer Pipeline Non-small Cell Lung Cancer Pipeline Insight … Cell Lung Cancer Epidemiology Forecast Non-small Cell Lung Cancer Epidemiology …
-
KRAS, EGFR, and the Future of Lung Cancer Treatment
26 Feb 2025 15:30 GMT
… developments in the field of lung cancer in 2024.
I think … trial comparing sotorasib with docetaxel, which showed between a … a marginal advantage over docetaxel in randomized trials, along … could beat docetaxel.
However, please remember that docetaxel is an …
-
The Inter-Relationships Among the Risk Factors for Pulmonary Infection and the Diagnostic Utility of Inflammatory Markers in Patients with Non-Small Cell Lung Cancer
25 Feb 2025 02:55 GMT
… lung cancer is the highest in China, and lung cancer … non-small-cell lung cancer. Clin Lung Cancer. 2021;22(2 … advanced non-small cell lung cancer treated with chemoradiotherapy. … docetaxel in patients with platinum-treated advanced non-small-cell lung cancer …